PT  - JOURNAL ARTICLE
AU  - Sen Pei
AU  - Sasikiran Kandula
AU  - Jeffrey Shaman
TI  - Differential Effects of Intervention Timing on COVID-19 Spread in the United States
AID  - 10.1101/2020.05.15.20103655
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.15.20103655
4099  - http://medrxiv.org/content/early/2020/05/20/2020.05.15.20103655.short
4100  - http://medrxiv.org/content/early/2020/05/20/2020.05.15.20103655.full
AB  - Assessing the effects of early non-pharmaceutical interventions1–5 on COVID-19 spread in the United States is crucial for understanding and planning future control measures to combat the ongoing pandemic6–10. Here we use county-level observations of reported infections and deaths11, in conjunction with human mobility data12 and a metapopulation transmission model13,14, to quantify changes of disease transmission rates in US counties from March 15, 2020 to May 3, 2020. We find significant reductions of the basic reproductive numbers in major metropolitan areas in association with social distancing and other control measures. Counterfactual simulations indicate that, had these same control measures been implemented just 1–2 weeks earlier, a substantial number of cases and deaths could have been averted. Specifically, nationwide, 61.6% [95% CI: 54.6%-67.7%] of reported infections and 55.0% [95% CI: 46.1%-62.2%] of reported deaths as of May 3, 2020 could have been avoided if the same control measures had been implemented just one week earlier. We also examine the effects of delays in re-implementing social distancing following a relaxation of control measures. A longer response time results in a stronger rebound of infections and death. Our findings underscore the importance of early intervention and aggressive response in controlling the COVID-19 pandemic.Competing Interest StatementJS and Columbia University disclose partial ownership of SK Analytics. JS discloses consulting for BNI.Funding StatementThis study was supported by funding from the National Institutes of Health (GM110748) and the National Science Foundation (DMS-2027369), as well as a gift from the Morris-Singer Foundation. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll input data are publicly available. The counterfactual simulation outcomes for daily cases and deaths in 3142 US counties, as well as the estimated effective reproductive number for the 311 counties with over 400 cumulative cases as of May 3 2020, are available at https://github.com/shaman-lab/Counterfactual.https://github.com/shaman-lab/Counterfactual